Rime Bioinformatics, founded in 2021, is a research and development biotechnology company headquartered in France. Specializing in bioinformatics, their slogan, "Making high performance bioinformatics accessible," underscores their mission to democratize cutting-edge bioinformatics.
The company focuses on expediting research in medical, agronomic, and veterinary fields. Their services provide comprehensive insights into bacterial and bacteriophage genomes, a critical step for advancing phage therapy in the market. This focus aligns well with the industry's increasing emphasis on sustainable and safe therapeutic solutions.
Positioned at the intersection of Biotechnology and Clean Energy, Rime Bioinformatics benefits from the supportive backing of AGORANOV, which provided non-equity assistance in June 2022. As it seeks to expand its influence in bioinformatics and phage therapy, Rime Bioinformatics is poised for growth in dynamic and environmentally conscious sectors.